Hi Team,
Through April 30, we have already helped close to 140K patients. We appreciate the continued commitment from all team members to ensure that patients get the help that they need as quickly as possible.
We have defined clear objectives and key results for 2023. Through April, we are on track for 7 of 13 key results and are still forecasting to deliver on all 12 of 13 by year-end. The only one that we are lowering expectations for is +55 Customer NPS. We have had a difficult time reducing the excess backlog and therefore patient turnaround time remains too high. We need to remove the excess backlog and keep patient turnaround times down to win back the confidence of our customers.
Build a diverse, equitable, inclusive, and engaged culture.
We are ensuring that we have an engaged team. We are executing a comprehensive employee engagement plan with the help of employee engagement sub-committees to ensure that eHealth Technologies is a great place to work.
Deliver on customer expectations.
We made some progress here in April and can see the light at the end of the tunnel to eliminate the excess backlog. The team continues to make progress on decreasing excess backlog and turnaround time to deliver on customer expectations.
Move relationship from vendor to strategic partner with key customers.
The struggle to deliver on customer expectations has made it difficult to move from vendor to strategic partner with key customers. The Customer Success team is proactively managing our customers and is now sharing what changes we made to improve patient turnaround time as well as what changes we made to avoid getting into a state of excess backlog again.
Transition from a service to a health care technology and analytics company.
We are rebranding to show how we differentiate through technology today. We are building a world-class product development organization to manage opportunities in the funnel which include decreasing records retrieval turnaround time and continuing to improve productivity and delivering actionable insights (clinical trial patient screening, clinical summaries).
Grow through expansion with strategic customers, addition of new key customers and adjacent markets.
We did not close many deals in April but have built a solid pipeline and are forecasting that we will be able to be back on track by the end of the third quarter.
Thank you for your continued support for our customers and patients. We are continuing to make sure that we live our value of our people to properly support you.
Regards,
Dan